Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Redhill Biopharma (NASDAQ:RDHL) shares rose 118.7% to $0.69 during Monday’s pre-market session. The market value of their…
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Heart Test Laboratories (NASDAQ:HSCS) stock rose 23.9% to $0.24 during Wednesday’s pre-market session. The company’s market cap…
Why Children’s Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Why Is Cancer Firm Apollomics Stock Trading Higher Today?
Apollomics Inc's (NASDAQ: APLM) partner in China, Avistone Biotechnology Co.
US Stocks Down; Jobless Claims Rise To 231,000
U.S. stocks traded lower this morning, following the release of jobless claims data.
Following the market opening Thursday, the Dow traded down 0.23% to 34,911.22 while the NASDAQ fell 0.19% to 14,076.92. The S&P 500 also fell, dropping, 0.09% to 4,498.72.
Apollomics Announces The First Approval Of Vebreltinib For MET Exon 14 Skip Non-Small Cell Lung Cancer
Apollomics' partner, Avistone Biotechnology, received approval from Chinese National Medical Products Administration (NMPA) to commercialize vebreltinib (APL-101) in China Compelling clinical data serving as basis
Apollomics Announces Two New Cohorts In Global Phase 2 SPARTA Study Of Vebreltinib In Non-Small Cell Lung Cancer And Other Solid Tumors With MET Dysregulation
The first new cohort, labeled C-2, is evaluating the addition of vebreltinib to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, such as osimertinib, for patients with EGFR-mutated NSCLC progressing on
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Apollomics (NASDAQ:APLM) stock rose 66.2% to $0.94 during Friday’s regular session. Apollomics’s stock is trading at a…
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.